Neoadjuvant chemotherapy for stage III breast cancer: Does the addition of paclitaxel to doxorubicin increase complete response. A single institution non randomized study

Autor: Alvarez, A., Rodger, J., Brosio, C., Cinat, G., Gigilio, R., Carnaval, S., Morgado, C. Cresta, Nobli´a, C., Delfino, C., Mickiewicz, E.
Zdroj: European Journal of Cancer; 2002, Vol. 38 Issue: 1 pS73-S73, 1p
Databáze: Supplemental Index